"10.1371_journal.pone.0056714","plos one","2013-02-19T00:00:00Z","Alessandra Cesano; Santosh Putta; David B Rosen; Aileen C Cohen; Urte Gayko; Kavita Mathi; John Woronicz; Rachael E Hawtin; Larry Cripe; Zhuoxin Sun; Martin S Tallman; Elisabeth Paietta","Nodality, Inc., South San Francisco, California, United States of America; Eastern Cooperative Oncology Group (ECOG), Boston, Massachusetts, United States of America; Indiana University Simon Cancer Center, Indianapolis, Indiana, United States of America; Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America; Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Montefiore Medical Center North Division, Bronx, New York, United States of America","Conceived and designed the experiments: AC SP DBR UG LC EP. Performed the experiments: DBR JW KM. Analyzed the data: AC SP DBR ACC UG REH ZS EP JW KM. Contributed reagents/materials/analysis tools: EP LC ZS MST. Wrote the paper: AC SP DBR ACC UG REH LC ZS MST EP.","AC, SP, DBR, ACC, UG, JW, and REH are employees and shareholders of Nodality, Inc., the funder of this study. KM is a consultant for Nodality, Inc. LC, ZS, MST, and EP have no competing interests. There are no products in development or marketed products to declare; however, the authors have submitted two patents entitled “METHODS FOR DIAGNOSIS, PROGNOSIS, AND METHODS FOR TREATMENT” (Application # US 2011/0104717, Published May 5th, 2011 and Application # 14/293673, Filed November 22nd, 2012) on a subset of the findings. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","02","Alessandra Cesano","AC",12,FALSE,6,3,10,10,TRUE,TRUE,FALSE,0,NA,FALSE
